Next Financial Group’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-4,625
Closed -$371K 2519
2016
Q4
$371K Sell
4,625
-75
-2% -$5.95K 0.07% 314
2016
Q3
$375K Buy
4,700
+150
+3% +$12.1K 0.07% 301
2016
Q2
$354K Buy
4,550
+150
+3% +$10.7K 0.11% 188
2016
Q1
$242K Buy
4,400
+325
+8% +$17.7K 0.09% 241
2015
Q4
$251K Buy
4,075
+100
+3% +$6.31K 0.09% 224
2015
Q3
$250K Buy
3,975
+100
+3% +$7.14K 0.09% 240
2015
Q2
$283K Sell
3,875
-50
-1% -$3.61K 0.1% 222
2015
Q1
$256K Sell
3,925
-25
-0.6% -$1.66K 0.08% 260
2014
Q4
$257K Buy
3,950
+833
+27% +$53.6K 0.09% 254
2014
Q3
$187K Buy
3,117
+2,925
+1,523% +$191K 0.04% 472
2014
Q2
$12K Buy
+192
New +$12.4K 0.01% 751

Other funds holding STJ

Next Financial Group's STJ Position: Q1 2017 in Review

Next Financial Group sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 4,625 shares — an estimated $371K sold.

Next Financial Group first reported a position in STJ in Q2 2014 and held it in 11 quarters. The position peaked at $375K in Q3 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Next Financial Group reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Next Financial Group sold 4,625 St Jude Medical shares in Q1 2017, an estimated $371K.
  • Next Financial Group first reported a position in St Jude Medical in Q2 2014 and held it in 11 quarters.
  • Next Financial Group's St Jude Medical position peaked at $375K in Q3 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Next Financial Group's 13F filing for Q1 2017, filed 8 May 2017.